Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia
Gespeichert in:
| Veröffentlicht in: | Journal of clinical oncology 2012-11, Vol.30 (31), p.3876-3883 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3883 |
|---|---|
| container_issue | 31 |
| container_start_page | 3876 |
| container_title | Journal of clinical oncology |
| container_volume | 30 |
| creator | KANTARJIAN, Hagop THOMAS, Deborah WAYNE, Alan S O'BRIEN, Susan |
| description | |
| doi_str_mv | 10.1200/JCO.2012.41.6768 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3478578</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>22891271</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-252c9e6f9e488ef4a673f6e2268509d24da837de613ef90e88e82733e01cf20b3</originalsourceid><addsrcrecordid>eNpVkEtP6zAQRi0EgvLYs7ryhmWKX7EdFlcq5a0CmyKxM64zvjUkcRWnoP57UvG6rGYx5_tmdBA6pGRIGSHHN-P7ISOUDQUdSiX1BhrQnKlMqTzfRAOiOMuo5o87aDelZ0Ko0DzfRjuM6YIyRQfo6TY20VWxsRUeNV2YxXKVndoEJZ7OobWLAOkEj_AdvOEz-9bg0OBuDnjagu1qaDocPR65ZQd4sqoX8zirbOqCwxNYvkAd7D7a8rZKcPA599DDxfl0fJVN7i-vx6NJ5gSTXcZy5gqQvgChNXhhpeJeAmNS56QomSit5qoESTn4gkAPaaY4B0KdZ2TG99Dfj97FclZD6frXWluZRRtq265MtMH83jRhbv7FV8OF0rnSfQH5KHBtTKkF_52lxKxtm962Wds2gpq17T7y5_-b34EvvT1w9AnY5GzlW9u4kH44mQtBScHfAYPBiOQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia</title><source>MEDLINE</source><source>American Society of Clinical Oncology Online Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>KANTARJIAN, Hagop ; THOMAS, Deborah ; WAYNE, Alan S ; O'BRIEN, Susan</creator><creatorcontrib>KANTARJIAN, Hagop ; THOMAS, Deborah ; WAYNE, Alan S ; O'BRIEN, Susan</creatorcontrib><identifier>ISSN: 0732-183X</identifier><identifier>EISSN: 1527-7755</identifier><identifier>DOI: 10.1200/JCO.2012.41.6768</identifier><identifier>PMID: 22891271</identifier><language>eng</language><publisher>Alexandria, VA: American Society of Clinical Oncology</publisher><subject>Antibodies, Monoclonal - administration & dosage ; Antibodies, Monoclonal - adverse effects ; Antibodies, Monoclonal - therapeutic use ; Antibodies, Monoclonal, Murine-Derived - administration & dosage ; Antibodies, Monoclonal, Murine-Derived - adverse effects ; Antibodies, Monoclonal, Murine-Derived - therapeutic use ; Antineoplastic Agents - administration & dosage ; Antineoplastic Agents - adverse effects ; Antineoplastic Agents - therapeutic use ; Biological and medical sciences ; Hematologic and hematopoietic diseases ; Humans ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Medical sciences ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy ; Review ; Rituximab ; Tumors</subject><ispartof>Journal of clinical oncology, 2012-11, Vol.30 (31), p.3876-3883</ispartof><rights>2015 INIST-CNRS</rights><rights>2012 by American Society of Clinical Oncology 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-252c9e6f9e488ef4a673f6e2268509d24da837de613ef90e88e82733e01cf20b3</citedby><cites>FETCH-LOGICAL-c426t-252c9e6f9e488ef4a673f6e2268509d24da837de613ef90e88e82733e01cf20b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,778,782,883,3718,27911,27912</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26544109$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22891271$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KANTARJIAN, Hagop</creatorcontrib><creatorcontrib>THOMAS, Deborah</creatorcontrib><creatorcontrib>WAYNE, Alan S</creatorcontrib><creatorcontrib>O'BRIEN, Susan</creatorcontrib><title>Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia</title><title>Journal of clinical oncology</title><addtitle>J Clin Oncol</addtitle><subject>Antibodies, Monoclonal - administration & dosage</subject><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antibodies, Monoclonal, Murine-Derived - administration & dosage</subject><subject>Antibodies, Monoclonal, Murine-Derived - adverse effects</subject><subject>Antibodies, Monoclonal, Murine-Derived - therapeutic use</subject><subject>Antineoplastic Agents - administration & dosage</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Medical sciences</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</subject><subject>Review</subject><subject>Rituximab</subject><subject>Tumors</subject><issn>0732-183X</issn><issn>1527-7755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkEtP6zAQRi0EgvLYs7ryhmWKX7EdFlcq5a0CmyKxM64zvjUkcRWnoP57UvG6rGYx5_tmdBA6pGRIGSHHN-P7ISOUDQUdSiX1BhrQnKlMqTzfRAOiOMuo5o87aDelZ0Ko0DzfRjuM6YIyRQfo6TY20VWxsRUeNV2YxXKVndoEJZ7OobWLAOkEj_AdvOEz-9bg0OBuDnjagu1qaDocPR65ZQd4sqoX8zirbOqCwxNYvkAd7D7a8rZKcPA599DDxfl0fJVN7i-vx6NJ5gSTXcZy5gqQvgChNXhhpeJeAmNS56QomSit5qoESTn4gkAPaaY4B0KdZ2TG99Dfj97FclZD6frXWluZRRtq265MtMH83jRhbv7FV8OF0rnSfQH5KHBtTKkF_52lxKxtm962Wds2gpq17T7y5_-b34EvvT1w9AnY5GzlW9u4kH44mQtBScHfAYPBiOQ</recordid><startdate>20121101</startdate><enddate>20121101</enddate><creator>KANTARJIAN, Hagop</creator><creator>THOMAS, Deborah</creator><creator>WAYNE, Alan S</creator><creator>O'BRIEN, Susan</creator><general>American Society of Clinical Oncology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20121101</creationdate><title>Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia</title><author>KANTARJIAN, Hagop ; THOMAS, Deborah ; WAYNE, Alan S ; O'BRIEN, Susan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-252c9e6f9e488ef4a673f6e2268509d24da837de613ef90e88e82733e01cf20b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antibodies, Monoclonal - administration & dosage</topic><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antibodies, Monoclonal, Murine-Derived - administration & dosage</topic><topic>Antibodies, Monoclonal, Murine-Derived - adverse effects</topic><topic>Antibodies, Monoclonal, Murine-Derived - therapeutic use</topic><topic>Antineoplastic Agents - administration & dosage</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Medical sciences</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</topic><topic>Review</topic><topic>Rituximab</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KANTARJIAN, Hagop</creatorcontrib><creatorcontrib>THOMAS, Deborah</creatorcontrib><creatorcontrib>WAYNE, Alan S</creatorcontrib><creatorcontrib>O'BRIEN, Susan</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KANTARJIAN, Hagop</au><au>THOMAS, Deborah</au><au>WAYNE, Alan S</au><au>O'BRIEN, Susan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia</atitle><jtitle>Journal of clinical oncology</jtitle><addtitle>J Clin Oncol</addtitle><date>2012-11-01</date><risdate>2012</risdate><volume>30</volume><issue>31</issue><spage>3876</spage><epage>3883</epage><pages>3876-3883</pages><issn>0732-183X</issn><eissn>1527-7755</eissn><cop>Alexandria, VA</cop><pub>American Society of Clinical Oncology</pub><pmid>22891271</pmid><doi>10.1200/JCO.2012.41.6768</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0732-183X |
| ispartof | Journal of clinical oncology, 2012-11, Vol.30 (31), p.3876-3883 |
| issn | 0732-183X 1527-7755 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3478578 |
| source | MEDLINE; American Society of Clinical Oncology Online Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived - administration & dosage Antibodies, Monoclonal, Murine-Derived - adverse effects Antibodies, Monoclonal, Murine-Derived - therapeutic use Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Biological and medical sciences Hematologic and hematopoietic diseases Humans Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Medical sciences Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Review Rituximab Tumors |
| title | Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T12%3A35%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Monoclonal%20Antibody-Based%20Therapies:%20A%20New%20Dawn%20in%20the%20Treatment%20of%20Acute%20Lymphoblastic%20Leukemia&rft.jtitle=Journal%20of%20clinical%20oncology&rft.au=KANTARJIAN,%20Hagop&rft.date=2012-11-01&rft.volume=30&rft.issue=31&rft.spage=3876&rft.epage=3883&rft.pages=3876-3883&rft.issn=0732-183X&rft.eissn=1527-7755&rft_id=info:doi/10.1200/JCO.2012.41.6768&rft_dat=%3Cpubmed_cross%3E22891271%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/22891271&rfr_iscdi=true |